Header Logo

Connection

CHADI CALARGE to Child

Back to Details
This is a "connection" page, showing publications CHADI CALARGE has written about Child.
CHADI CALARGE
Connection Strength
0.919
Child
  1. Iron Deficiency and Internalizing Symptoms Among Adolescents in the National Health and Nutrition Examination Survey. Nutrients. 2024 Oct 26; 16(21).
    View in: PubMed
    Score: 0.054
  2. Re: "Effects of Long-Term Sertraline Use on Pediatric Growth and Development: The Sertraline Pediatric Registry for The Evaluation of Safety (SPRITES)" by Kolitsopoulos et al. J Child Adolesc Psychopharmacol. 2023 09; 33(7):294.
    View in: PubMed
    Score: 0.049
  3. Utilization and Predictors of Adjuvant Metformin for Children and Adolescents on Mixed Receptor Antagonists (Second-Generation Antipsychotics). J Am Acad Child Adolesc Psychiatry. 2023 11; 62(11):1245-1255.
    View in: PubMed
    Score: 0.049
  4. Iron Deficiency in Attention-Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Internalizing and Externalizing Disorders, and Movement Disorders. Child Adolesc Psychiatr Clin N Am. 2023 04; 32(2):451-467.
    View in: PubMed
    Score: 0.048
  5. Iron deficiency and internalizing symptom severity in unmedicated adolescents: a pilot study. Psychol Med. 2023 04; 53(6):2274-2284.
    View in: PubMed
    Score: 0.044
  6. First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome. BMC Psychiatry. 2019 04 24; 19(1):123.
    View in: PubMed
    Score: 0.037
  7. Gut permeability and depressive symptom severity in unmedicated adolescents. J Affect Disord. 2019 03 01; 246:586-594.
    View in: PubMed
    Score: 0.036
  8. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys. J Pediatr. 2018 10; 201:245-251.
    View in: PubMed
    Score: 0.035
  9. Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study. J Child Adolesc Psychopharmacol. 2018 03; 28(2):145-150.
    View in: PubMed
    Score: 0.033
  10. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. J Child Adolesc Psychopharmacol. 2017 Dec; 27(10):908-915.
    View in: PubMed
    Score: 0.033
  11. Bone Mass in Boys with Autism Spectrum Disorder. J Autism Dev Disord. 2017 06; 47(6):1749-1755.
    View in: PubMed
    Score: 0.032
  12. Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth. J Child Adolesc Psychopharmacol. 2016 06; 26(5):471-7.
    View in: PubMed
    Score: 0.029
  13. Iron homeostasis during risperidone treatment in children and adolescents. J Clin Psychiatry. 2015 Nov; 76(11):1500-5.
    View in: PubMed
    Score: 0.029
  14. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children. Transl Psychiatry. 2015 Oct 06; 5:e652.
    View in: PubMed
    Score: 0.029
  15. Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys. J Clin Psychiatry. 2015 May; 76(5):607-13.
    View in: PubMed
    Score: 0.028
  16. The effect of psychostimulants on skeletal health in boys co-treated with risperidone. J Pediatr. 2015 Jun; 166(6):1449-54.e1.
    View in: PubMed
    Score: 0.028
  17. Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment. J Child Adolesc Psychopharmacol. 2014 Apr; 24(3):120-9.
    View in: PubMed
    Score: 0.026
  18. Iron deficiency in pediatric patients in long-term risperidone treatment. J Child Adolesc Psychopharmacol. 2013 Mar; 23(2):101-9.
    View in: PubMed
    Score: 0.024
  19. Rate of weight gain and cardiometabolic abnormalities in children and adolescents. J Pediatr. 2012 Dec; 161(6):1010-5.
    View in: PubMed
    Score: 0.023
  20. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics. J Clin Psychiatry. 2011 Dec; 72(12):1685-90.
    View in: PubMed
    Score: 0.022
  21. Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. J Child Adolesc Psychopharmacol. 2011 Apr; 21(2):163-9.
    View in: PubMed
    Score: 0.021
  22. Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010 Dec; 20(6):495-502.
    View in: PubMed
    Score: 0.020
  23. Iron status in toddlerhood predicts sensitivity to psychostimulants in children. J Atten Disord. 2012 May; 16(4):295-303.
    View in: PubMed
    Score: 0.020
  24. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. J Clin Psychiatry. 2010 Mar; 71(3):338-47.
    View in: PubMed
    Score: 0.019
  25. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr Genet. 2009 Dec; 19(6):320-7.
    View in: PubMed
    Score: 0.019
  26. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics. 2009 May; 19(5):373-82.
    View in: PubMed
    Score: 0.018
  27. Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):101-9.
    View in: PubMed
    Score: 0.018
  28. Fluoxetine for depression relapse prevention. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):966-7; author reply 967-8.
    View in: PubMed
    Score: 0.014
  29. Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child Psychiatrists. J Child Adolesc Psychopharmacol. 2024 Oct; 34(8):359-365.
    View in: PubMed
    Score: 0.013
  30. The Effectiveness of Metformin in Managing Second Generation Antipsychotic-Induced Weight Gain in Children and Adolescents. J Clin Psychiatry. 2023 Dec 20; 85(1).
    View in: PubMed
    Score: 0.013
  31. Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics. Psychiatr Serv. 2024 Apr 01; 75(4):342-348.
    View in: PubMed
    Score: 0.012
  32. Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics. J Child Adolesc Psychopharmacol. 2023 09; 33(7):269-278.
    View in: PubMed
    Score: 0.012
  33. Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents. J Psychiatr Res. 2023 09; 165:170-173.
    View in: PubMed
    Score: 0.012
  34. Machine Learning-Based Aggression Detection in Children with ADHD Using Sensor-Based Physical Activity Monitoring. Sensors (Basel). 2023 May 21; 23(10).
    View in: PubMed
    Score: 0.012
  35. Prolactin serum concentrations during aripiprazole treatment in youth. J Child Adolesc Psychopharmacol. 2013 May; 23(4):282-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.